• 9207 Citations
  • 40 h-Index
1991 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1992 2021


DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health


Project: Research project

Organized Financing
Research Personnel
Clinical Trials


Kelly, K., Prochazka, A., Degregori, J. V., Pettijohn, D., Heasley, L., Kane, M., Kazlauskas, A., Drabkin, H. A., Baron, A., Keith, R., Merrick, D. T., Kennedy, T., Gemmill, R., Sclafani, R., Archer, P., Anderson, M., Johnson, G., Stevens, J., Nemenoff, R. A., Franklin, W., Miller, Y. & Bunn, P.

National Institutes of Health


Project: Research project

Tissue and Organ Procurement
Clinical Trials
Lung Neoplasms
Translational Medical Research

Research Output 1991 2019

Clinical prognostic model for older patients with advanced non-small cell lung cancer

Ganti, A. K., Wang, X., Stinchcombe, T. E., Wang, Y., Bradley, J., Cohen, H. J., Kelly, K., Paulus, R., Ramalingam, S. S., Vokes, E. E. & Pang, H., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Weight Loss
Proportional Hazards Models
ROC Curve
1 Citation (Scopus)

Efficacy and Safety of Avelumab for Patients with Recurrent or Refractory Ovarian Cancer: Phase 1b Results from the JAVELIN Solid Tumor Trial

Disis, M. L., Taylor, M. H., Kelly, K., Beck, J. T., Gordon, M., Moore, K. M., Patel, M. R., Chaves, J., Park, H., Mita, A. C., Hamilton, E. P., Annunziata, C. M., Grote, H. J., Von Heydebreck, A., Grewal, J., Chand, V. & Gulley, J. L., Jan 1 2019, (Accepted/In press) In : JAMA oncology.

Research output: Contribution to journalArticle

Patient Safety
Ovarian Neoplasms

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review

Abdel Karim, N. & Kelly, K., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Molecular Diagnostic Techniques
Clinical Trials

Abemaciclib in combination with single-agent options in patients with stage IV non–small cell lung cancer: A phase Ib study

Kim, E. S., Kelly, K., Paz-Ares, L. G., Garrido, P., Jalal, S., Mahadevan, D., Gutierrez, M., Provencio, M., Schaefer, E., Shaheen, M., Johnston, E. L., Kellie Turner, P., Kambhampati, S. R. P., Beckmann, R., Hossain, A., John, W. J. & Goldman, J. W., Nov 15 2018, In : Clinical Cancer Research. 24, 22, p. 5543-5551 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Appointments and Schedules
Cyclin-Dependent Kinase 6

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

Liu, S. V., Groshen, S. G., Kelly, K., Reckamp, K. L., Belani, C., Synold, T. W., Goldkorn, A., Gitlitz, B. J., Cristea, M. C., Gong, I. Y., Semrad, T., Xu, Y., Xu, T., Koczywas, M., Gandara, D. R. & Newman, E. M., Jan 1 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells